SINO BIOPHARMACEUTICAL earnings per share and revenue

1177 earnings per share for the last semiannual are 0.05 HKD whereas the estimation was 0.09 HKD which accounts for -43.75% surprise. Företagets omsättning för samma period uppgår till 12.02 B HKD trots den uppskattade siffran 16.42 B HKD. Estimated earnings per share for the next semiannual are 0.09 HKD, and revenue is expected to reach 16.60 B HKD. Also watch annual changes over time to get a bigger picture of 1177 earnings per share and revenue dynamics.